Updated:
Vaxxinity, Inc.
Vaxxinity, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001851657, and its reported industry is...
Overview
Vaxxinity, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001851657, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-27, it reported net income of USD -56,934,000; total assets of USD 44,311,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Vaxxinity, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Exploration Park, FL, United States
- Incorporated in
- FL
- Fiscal year end
- December 31
- SEC CIK
- 0001851657
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2023USD | — | -$56.9M | $44.3M | $4.9M | -$57.2M | |
| FY2022USD | $0 | -$75.2M | $106.4M | $33.5M | -$55.9M | |
| FY2021USD | $66,000 | -$137.2M | $166.7M | $144.9M | -$81.0M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-K/A | FORM 10-K/A | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | FORM 8K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8K | ||
| 8-K | FORM 8K | ||
| 10-Q | FORM 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Vaxxinity, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.